REVELATION BIOSCIENCES, INC. (REVB) Operating income 2021–2025
REVELATION BIOSCIENCES, INC. (REVB) annual operating income history from SEC filings — each fiscal year as reported.
-$9.1MFY2025 · since FY2021: -$12.0M → -$9.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.1M | -13.7% |
| FY2024 | -$8.0M | +7.9% |
| FY2023 | -$8.7M | +20.3% |
| FY2022 | -$10.9M | +9.1% |
| FY2021 | -$12.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REVB financial trends
REVB RevenueREVB Net incomeREVB Net marginREVB Gross profitREVB Gross marginREVB Operating marginREVB Operating cash flowREVB Free cash flowREVB Capital expendituresREVB Return on equityREVB Stock buybacksREVB Dividends paidREVB Total assetsREVB Total liabilitiesREVB Shareholders’ equityREVB overview →